Thermo Fisher Scientific launches ‘Make in India’ Air Quality Monitoring Systems to support India’s clean air initiatives

▴ Thermo Fisher Scientific
Thermo Fisher offers the industry’s most comprehensive line of environment monitoring systems such as CAAQMS and CEMS for detecting a broad range of gaseous and aerosol pollutants.

Pune, 27th May 2024: Thermo Fisher Scientific, the world leader in serving science, has announced the commencement of manufacturing of Air Quality Monitoring System (AQMS) analyzers in India. The analyzers will be engineered, manufactured and validated at Thermo Fisher’s facility at Nasik, Maharashtra.

Thermo Fisher has been supporting leading players in cement, metals, mining, oil and gas, power, chemicals and other industries in India with these analyzers, manufactured at its facilities in the USA and China. The analyzers are then assembled into Make in India Class 1 Continuous Ambient Air Quality Monitoring Station (CAAQMS) at its Pune facility.

By now manufacturing these analyzers in India, Thermo Fisher has further fortified its commitment to India’s localization and environmental stewardship efforts.

Designed to provide accurate data on air pollutants and gases, the AQMS analyzers play a crucial role in monitoring and regulating industrial emissions, contributing to the government’s efforts in curbing air pollution.

Mr. Jatinder Singh Kamyotra, former Member Secretary and Director of Central Pollution Control Board, a key figure in India’s clean air initiatives, believes that the availability of these Make in India Class 1 CAAQMS will strengthen the monitoring network. Speaking at the launch he stated, “The localization will minimize downtime for the availability of these analyzers and enable stakeholders to provide better quality data to formulate policies to positively impact the environment.”

 

Mr. Nihar Sahoo, Ph. D., Chief Environmental Engineer, State Pollution Control Board and Head of the National Clean Air Programme, Odisha, further added, “The National Clean Air Programme aims at reducing air pollution by 20-40% with a focus on reduction of Pollutants PM10 and PM2.5. To ensure that we achieve these ambitious targets, there is a need for high-quality equipment that provides accurate and consistent baseline data on the particulate and gas pollutants. The programme was initiated in 2019 and since most of the systems, particularly for continuous air monitoring were imported, we faced many challenges in the operations and maintenance of these systems. The availability of Make in India Class 1 CAAQMS systems is likely to reduce the overall cost and turnaround time, thereby accelerating the effective implementation of the program.”

 

Thermo Fisher offers the industry’s most comprehensive line of environment monitoring systems such as CAAQMS and CEMS for detecting a broad range of gaseous and aerosol pollutants.

 

Miguel Faustino, President, Chemical Analysis, Thermo Fisher Scientific, highlighted the company’s commitment to India’s sustainable business environment, saying, “Thermo Fisher’s Mission to enable our customer to make the world healthier, cleaner and safer is aligned to India’s ambitious sustainability goals. The localization of our industry-leading innovations reflects our ongoing investments to address the complex environmental and process monitoring challenges in the country."

 

Srinath Venkatesh, Managing Director, India & South Asia, Thermo Fisher Scientific, emphasized the significance of these efforts, stating, “Air pollution remains a major challenge in India, impacting the health and well-being of millions. By investing in localized capabilities, we strive to strengthen our partnership with government and regulatory stakeholders for action-oriented measures for a healthier, cleaner and safer India.”

 

Thermo Fisher’s monitoring solutions have been instrumental in helping manufacturing plants across industries such as food and beverage, oil and gas, petrochemicals, power generation, steel and metals, and mining, operate safely, efficiently and in compliance.


The company established operations in India in 1996, continually expanding its operations and reach across the country. With its headquarters in Mumbai, the company has an employee strength of over 4400 employees operating in 42 cities.  Through its extensive capabilities, including eight distribution centers, eight manufacturing facilities, five application labs and two R&D centers, supported by an extensive network of 400-plus channel partners, Thermo Fisher offers advanced technologies to meet the diverse needs of its customers in India.

 

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

The Future of Indian MedTech Exports: Can India Compete With Global Leaders?September 17, 2026
Robotic-Assisted Procedures Beyond Surgery: Where Is Automation Going Next in Healthcare?September 17, 2026
Tracky launches 16D, India's first 16-day continuous glucose monitoring system (CGM)September 16, 2026
Why Local Medical Device Manufacturing Matters for Indian HealthcareSeptember 16, 2026
Next-Generation Surgical Robots Entering the Indian Market: What It Means for Patients and ProvidersSeptember 16, 2026
ShardaCare - Healthcity Marks World Sepsis Day with Training for Over 50 NursesSeptember 15, 2026
From Empowerment to Ownership: Upasana Kamineni Konidela Calls for a BRICS Women’s Economic CorridorSeptember 15, 2026
WORLD HEART DAY 2026: Don't Miss a Beat: The Heart Attacks That Never Had to HappenSeptember 15, 2026
BL Agro Announces Investment of ₹1,500 Crore In Its Biotech-Arm Leads Genetics To Build An Integrated Dairy and Genetics EcosystemSeptember 15, 2026
Can You Have PMOS With Regular Periods? What Women Often Get WrongSeptember 15, 2026
Hospital Data Breaches in India: What Every Patient Needs to Know Right NowSeptember 15, 2026
Cybersecurity of ICUs: Protecting Connected Critical-Care Systems in Indian HospitalsSeptember 15, 2026
Fortis Hospital, Shalimar Bagh Becomes Delhi NCR’s First Multi-speciality Hospital to Launch Rezūm™ Water Vapor Therapy for Enlarged ProstateSeptember 14, 2026
Dr. Reddy's Laboratories Launches Nationwide Educational Initiative to Strengthen India's Obesity Care WorkforceSeptember 14, 2026
IIM Bodh Gaya Hosts Convergence 3.0: The Next Frontier of Healthcare SectorSeptember 14, 2026
A Practical Guide to Fibre: How Indian Adults Can Add More Without Digestive DiscomfortSeptember 12, 2026
Understanding Heart Palpitations: Common Triggers, Helpful Records, and Warning SignsSeptember 12, 2026
The Fourth Trimester: Why Healthcare Often Stops Too Early After DeliverySeptember 12, 2026
Postpartum Mental Health: The Healthcare Gap Nobody Talks About EnoughSeptember 12, 2026
Fortis Escorts Faridabad Launches Region’s First Dedicated ‘Fever Clinic’ for Early Diagnosis and Timely TreatmentSeptember 11, 2026